Phase I trial of BTI 320 in healthy, but overweight, volunteers.
Phase of Trial: Phase I
Latest Information Update: 17 Oct 2014
Price : $35 *
At a glance
- Drugs BTI 320 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Boston Therapeutics
- 17 Oct 2014 New trial record
- 09 Oct 2014 Results published in the Media Release.